Professional Documents
Culture Documents
Methods Send reprint requests to Dr. M. Knapp, Director, Centre for the
Economics of Mental Health, Health Services Research Department,
Cost-of-Dlness Methods. Cost-of-illness studies identify Box P024, Institute of Psychiatry, De Crespigny Park, London SE5 8AF;
and measure the total societal burden of a disorder or dis- e-mail: cemh@iopJccl.ac.uk.
279
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
days necessary to fill the vacant position (the friction cost limitations on comparability, the national estimates pro-
method) plus the mean earnings of caregivers multiplied vide interesting information when read alongside contex-
by the number of days lost in performing their main activ- tual information and draw a useful picture about the
ity. health, health care, health policy, and economic impor-
tance of a disorder in each country. However, these diffi-
Literature Review. A systematic search was conducted culties should certainly caution against making any
using Medline, PsycINFO, EMBASE, and NHS EED data detailed cross-country comparisons of estimates.
bases in order to identify any studies across the world that
have estimated the total and/or component costs of schiz-
ophrenia. There were no limitations on publication date, Results
publication status, or language. Bibliographies of eligible
papers were checked for further studies. Unpublished Comparison of international cost findings are grouped by
studies were also sought. After removing duplicates, 62 countries under the following headings:
articles were selected as relevant to the topic and included • national total, direct, and indirect costs
in the review. • direct, indirect, and total costs per patient per year
Estimates of total, direct, and indirect costs were • costs of inpatient services
derived mainly from full cost-of-illness studies. Some • costs of drugs
data on specific components of costs such as inpatient • costs of lost productivity
280
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
281
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
billion represented 2.5 percent of total national health responsibilities. The indirect costs figure is an underesti-
care expenditure in 1990. As in the estimates for 1985, mate as mortality and morbidity costs were examined
morbidity and mortality cost estimations were based on over only 5 years rather than the lifetime.
the human capital approach. Total indirect costs were esti- Rouillon et al. (1997) estimated the direct costs of
mated to be $12.0 billion, of which $10.7 billion was schizophrenia in France to be Frl2.4 billion in 1992.
attributed to morbidity and $1.3 billion to mortality from Estimates were based on prevalence data derived from a
schizophrenia. Other related costs (direct and indirect) survey of patients treated by public, private, and commu-
were estimated to be $3.2 billion in 1990. Despite some nity psychiatrists. Indirect costs for lost employment were
expressed reservations, this remains the most comprehen- measured by social assistance allowances and accounted
sive and widely cited costing of schizophrenia. for Fr5.2 billion, which could be an underestimate unless
Wyatt et al. (1995) projected empirically obtained the allowances reflect average wages.
costs of schizophrenia from previous studies to 1991, Using incidence-based data for 1993-94, De Hert et
estimating the total economic burden of schizophrenia in al. (1998b) computed the mean annual health care cost of
the United States as $65 billion. treating a schizophrenia patient in Belgium as U.S.
Europe. In the United Kingdom, Davies and $12,050. With prevalence taken as 2.5 per 1,000, equiva-
Drummond (1994) estimated the annual average direct lent to 25,274 people in the country, the total annual cost
cost of treating a person with schizophrenia to be £2,138 amounted to $304 million, 1.9 percent of all government
and the annual treated prevalence of schizophrenia to be health care expenditure. Indirect costs were not estimated,
282
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
studies agree that few schizophrenia patients form part of ing a 40 percent reduction in incidence between 1976 and
the active workforce. 1990. The figures for 1990 were AUS$12.8 million in
Two studies provide somewhat different estimates of direct costs and AUSS56.7 million in indirect costs (with-
direct costs in Norway. Rund and Ruud (1999) calculated out costs for the prodrome phase).
costs of services from a 1994 register of the patient popula- Puerto Rico. Rubio-Stipec et al. (1994) estimated
tion using services over a 4-week period in six catchment the total and direct costs of schizophrenia in Puerto Rico,
areas. Their estimate of N0K1.2 billion is lower than the first adopting an incidence-based approach and then a
N0K1.8 billion reported by Rund (1995), which was based prevalence-based method. The huge differences in the
on official statistics. While Rund and Ruud (1999) did not estimates ($266.1 million vs. $60 million, $36.1 million
estimate indirect costs, Rund (1995) calculated them to vs. $19.58 million) provide a clear illustration of how the
amount to N0K1.7 billion, giving a total economic impact chosen methodology influences the calculation.
of NOK3.5 billion per year. Cost-of-illness figures are also
available for two other Scandinavian countries. The socioe- Direct, Indirect, and Total Costs Per Patient Per Year.
conomic cost of schizophrenia in Sweden was approxi- In table 2 all available direct, indirect, and total cost esti-
mately SEK12 billion in 1990 (JOnsson and Walinder mates are presented for the average patient year. These
1994). In Denmark, direct treatment costs were estimated at annual estimates vary greatly between countries, and
$562 million in 1992, although this did not include day care indeed sometimes between studies within a country, as a
and drugs (Lund 1994).
283
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
Table 2. Direct, Indirect, and total costs per patient per year
Cost Per Patient Per Yr
Country Source Year of costing Direct costs1 Indirect costs Total costs2
Australia Andrews 1985 1975 $11,074
Halletal. 1985 1975 $131,333
Langley-Hawthorne 1995 $12,191 $21,369 $33,560
19973
Belgium DeHertetal. 1998b 1994 $12,050 - -
Canada Goeree et al. 1999 1996 $4,602 $6,710 $11,312
Denmark Lund 19944 1992 $14,312 - -
5
Germany Hafneretal. 1986 1986 DM15,574
Salize and Rossler 1994 DM27,566
19965
Italy Moscarelli et al. 1991 1991 $5,678
Tarricone et al. 2000 1995 ITL14.82 million ITL34.54 million ITL49.36 million
284
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
cent for nursing home expenditures (Rice and Miller on schizophrenia care. Guest and Cookson (1999) placed
1996). These proportional contributions will doubtless the burden of hospitalization costs at 69 percent of all
have declined over time: a national cohort study found health care costs for their cohort of newly diagnosed
decreasing inpatient service costs between 1993 and 1995, patients.
falling from $12,429 to $9,506 per patient year (Leslie According to De Hert (1998a), hospitalization costs
and Rosenheck 1999). in Belgium accounted for 90 percent of all health care
The direct cost of treating schizophrenia in other expenditure for schizophrenia in 1994, although this could
countries is similarly dominated by hospitalization and be an overestimate as, under the Belgian hospital regula-
(increasingly over time) by community-based residential tions, day care is considered a form of hospitalization. In
services. For example, Davies and Drummond (1994) 1994, schizophrenia patients were estimated to have spent
found that hospital- and community-based residential care 2.4 million days in the hospital, claiming 38 percent of
accounted for nearly three-quarters of all direct costs in government expenditure on all psychiatric hospital beds
1990 in the United Kingdom, and that 97 percent of the and 8 percent of all government expenditure on inpatient
lifetime direct treatment costs of schizophrenia were services.
attributable to 41 percent of patients who had hospital Changes have been reported over time. A German
inpatient treatment episodes of 2.5 years or longer. study conducted in Mannheim found that 80 percent of
Evidence of such asymmetry was also observed by the direct health care costs in 1979-80 went for inpatient
Kavanagh et al. (1995): the 14 percent of schizophrenia treatment (Hafner et al. 1986), compared with 37 percent
patients who were in either short- or long-stay hospitals in in 1994-95 due in large part to the development of com-
1992 accounted for 51 percent of total public expenditure prehensive community care (Salize and Rossler 1996).
285
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
While the average service cost of community care for the Cost of Drugs. The contribution of drug costs to the total
cohort in the latter study was $18,377 per patient year, cost of treatment is generally modest, although it varies
long-term care in a long-term ward or in a hospital ward from country to country (table 4). In high-income coun-
of a state mental hospital costs $43,000 and $61,261 per tries, the proportion spent on medication usually lies
patient year, respectively. Italy also provides evidence of a between 1.1 percent and 9 percent of all direct health care
changing inpatient contribution to total costs, with an ear- costs. Differences reflect the structure of services, national
lier estimate of 41 percent (Moscarelli et al. 1991) com- pricing policies, the extent and methods of disaggregation
pared with only 17 percent more recently (Tarricone et al. of costs, and the market share of the more expensive atyp-
2000). ical antipsychotics. Not surprisingly, the drug-cost propor-
Long-term inpatient provision continues to dominate tion tends to be higher in countries where the service
expenditure patterns in some countries, however. In range is more limited and where the cost of inpatient
Norway, three-quarters of all direct health care costs were treatment is lower. This is vividly illustrated by a Nigerian
attributed to inpatient care in long-term hospital wards or study that found antipsychotic drugs accounted for 53 per-
psychiatric nursing homes, with acute and intermediate cent of total cost (Suleiman et al. 1997). As a proportion
length inpatient care costs representing another fifth of the direct costs only, the proportion is a staggering 61.8
(Rund and Ruud 1999). percent, reflecting the high acquisition costs of imported
Another characteristic of some studies is that some drugs and the typical practice of treating only in outpa-
tient settings.
286
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
stays, thus potentially reducing the total cost Indeed, in other studies in other countries point to the high rate of
the grander scheme of things, these more expensive treat- unemployment. In Nigeria, in contrast, "only" 44 percent
ments may actually prove to be cheaper for society, and of the patients were unemployed and the mean cost of lost
more cost effective if the efficacy of these drugs results in productivity was 445.2 Naira, which is 52 percent of the
fewer relapses, fewer inpatient admissions, and earlier total indirect costs. With a low average age of onset and
discharge of patients from hospitals (Sartorius et al. the largely chronic development of schizophrenia, the loss
2002). of productivity for the national economy can be very high,
although as Goeree et al. (1999) point out, the estimated
Costs of Lost Productivity. A large part of the global impact is highly dependent on the mode of calculation.
economic impact of mental illness stems from the diffi- Table 5 presents estimates for the value of lost productiv-
culties encountered by people with schizophrenia in find- ity due to schizophrenia-related morbidity and mortality.
ing and keeping paid employment. About a third of all For example, in the United States, Rice and Miller (1996)
sickness absence from work has been attributed to com- estimated lost productivity due to morbidity to be $8.1
mon mental disorders (Jenkins 1985; Almond and Healey billion in 1985 and $10.7 billion in 1990. Wyatt et al.
2003), and there are also large impacts on productivity at (1995) estimated the costs of lost labor of schizophrenia
the workplace (Kessler et al. 2001). In the case of schizo- patients to be approximately double the direct health care
phrenia, the most important feature of indirect costs is the costs.
loss of productivity because of patient morbidity and mor-
287
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
resulting in a loss of $1.0 billion to the American econ- that family cost was 17 percent of total indirect costs of
omy in 1985, and $1.3 billion in 1990. About 36 percent schizophrenia. The value of time committed by family
of the deaths were among persons aged 25 to 44 years, members to the care of mentally ill relatives was esti-
and they accounted for 56 percent of the total mortality mated to be $2 billion in 1985 and $2.5 billion or an
costs. Table 5 summarizes the international evidence on annual $11,519 per family in 1990. Terkelsen and
costs. Menikoff (1995) reported family impact costs amounting
to between $2.47 and $8.65 billion. Wyatt et al. (1995)
Family Impact Costs. With its chronic course and early supported that the loss of income incurred by relatives can
onset, schizophrenia can have substantial psychological be as high as productivity losses caused by suicide.
and economic impacts, not only on people with the ill- More than half of people with schizophrenia in the
ness, but also on their families. A five-country European United Kingdom live at home, often with a family mem-
study reported that family caregivers for adults with ber. A survey of 100 patients in the United Kingdom
schizophrenia spent on average from 6 to 9 hours per day found that 10 percent of families looking after someone
providing support (Magliano et al. 1998). The most com- with schizophrenia reported financial difficulties because
mon impacts reported were constraints on social activi- of the patient's illness: 3 percent had stopped work to look
ties, negative effects on family life, and feelings of loss. after the patient, and 7 percent had taken time off work.
Patients living in a family environment might impose Another study found that 16 percent of caregivers had
additional costs through household expenditure, travel stopped work to look after a relative with schizophrenia
288
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
Informal family care and formal services have been found percent of direct costs (table 7). A rough estimate for the
to be substitutes; in the long term, a 1 percent decrease in United Kingdom by Guest and Cookson (1999) is that
formal care costs for people with schizophrenia is associ- schizophrenia patients in prison and on remand cost £1.3
ated with a 4 to 6 percent increase in informal care hours million annually. In Canada, the cost of incarceration was
(Clark et al. 2001). In Spain, the cost of informal care per estimated to be $70 million in 1996, or nearly 3 percent of
patient was estimated to be $2,161 in Burlada, $1,686 in the total costs and 6 percent of direct costs (Goeree et al.
among the regions is mainly due to a more conservative 1999). In contrast to these results, in one Nigerian study it
interview technique in Cantabria. was found that none of the schizophrenia patients or their
In Italy, family costs have been found to represent families generated or incurred costs from crime, acci-
41.2 percent of all indirect costs (Tarricone et al. 2000) dents, or damages (Suleiman et al. 1997).
and in Hungary, 12.5 percent (Rupp et al. 1999). In
Nigeria, two studies found that financial impoverishment
constituted the greatest source of burden to families, fol- Conclusions
lowed by the effect on family routine and family interac-
tion (Martyns-Yellowe 1992; Ige 1993). Another study Cost-of-illness studies can provide useful information on
estimated the cost resulting from caregivers' loss of earn- the burden of a disorder to society. However, they do not
ings to be 415 Nairn, which amounted to 48 percent of all indicate the cost savings from eradication or reduction of
indirect costs (Suleiman et al. 1997). the disorder because of the continuing impact of comor-
289
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
illness studies may hide quite marked variations from one Andrews, G.; Hall, W.; Goldstein, G.; Lapsley, H.;
region to another. Bartels, R.; and Silove, D. The economic costs of schizo-
Notwithstanding these limitations, this international phrenia: Implications for public policy. Archives of
review of the costs of schizophrenia has shown clearly the General Psychiatry, 42(6):537-543, 1985.
magnitude and wide-ranging nature of the economic Arboledo-Florez, J.; Holley, HJ.; and Crisanti, A. Calgary
impacts of this devastating and distressing disorder. With World Health Organization Collaborating Centre for
very few exceptions, all of the evidence comes from Research and Training in Mental Health. Mental Illness and
developed countries. A number of conclusions can be Violence: Proof or Stereotype? Ottawa, Canada: Health
drawn: Promotion and Programs Branch, Health Canada, 1996.
• The full cost of schizophrenia is high and wide ranging.
Birmingham, L.; Mason, D.; and Grubin, D. Prevalence of
However, this full cost is rarely fully appreciated by
mental disorder in remand prisoners: Consecutive case
health care decision makers or other stakeholders.
study. British Medical Journal, 313:1521-1524, 19%.
• Schizophrenia is a chronic illness, and so its costs tend
to persist. Brooke, D.; Taylor, C ; Gunn, J.; and Maden, A. Point
• The impact of schizophrenia on health care budgets is prevalence of mental disorder in unconvicted male prison-
substantial, typically between 1.5 percent and 3 percent ers in England and Wales. British Medical Journal,
of total national health care expenditures. 313(7071):1524-1527, 19%.
• Sizeable proportions of total inpatient budgets are Clark, R.E.; Xie, H.; Adarhi-Meija, A.M.; and Sergupta,
290
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
gories de patients. Medicine Sociale et Preventive, general description of the sample. British Journal of
32:168-175, 1987. Psychiatry, 159 (Suppl 13):43-46,1991.
Foster, K.; Melzer, H.; Gill, B.; and Hinds, K. OPCS Jonsson, D., and Walinder, J. The socio-economic cost of
Surveys of Psychiatric Morbidity Report 8: Adults With a treatment of therapy refractory schizophrenic patients in
Psychiatric Disorder Living in the Community. London, Sweden. Nordic Journal of Psychiatry, 48:311-313, 1994.
UK: HMSO, 1996. Kavanagh, S.; Opit, L.; Knapp, M.; and Beecham, J.
Franks, D.D. Economic contribution of families caring for Schizophrenia: shifting the balance of care. Social
persons with severe and persistent mental illness. Psychiatry and Psychiatric Epidemiology, 30:206-212,
Administration and Policy in Mental Health, 18:9—18, 1995.
1990. Kessler, R.C.; Greenberg, P.E.; and Mickelson, K.D. The
Goeree, R.; O'Brien, B.J.; Goering, P.; Blackhouse, G.; effects of chronic mental health conditions on work loss
Agro, K.; Rhodes, A.; and Watson, J. The economic bur- and work cut back. Journal of Occupational and
den of schizophrenia in Canada, Canadian Journal of Environmental Medicine, 43:218-225, 2001.
Psychiatry, 44:464-^72, 1999. Kissling, W; Hoffler, J.; Seemann, U.; Muller, P.; Ruther,
Guest, J.F., and Cookson, R.F. Cost of schizophrenia to E.; Trenckmann, U.; Uber, A.; Graf von der Schulenburg,
U.K. society. Pharmacoeconomics, 15(6):597-610, 1999. J.M.; Glaser, P.; Glaser, T.; Mast, O.; and Schmidt, D. Die
Gunderson, J.G., and Mosher, L.R. The cost of schizo- direkten und indirekten kosten der schizophrenic
291
Schizophrenia Bulletin, Vol. 30, No. 2, 2004 M. Knapp et al.
care costs in Netherlands: Cost of illness study. British Rund, B.R., and Ruud, T. Cost of services for schizo-
MedicalJournal, 317:111-115, 1998. phrenic patients in Norway. Ada Psychiatrica
Monahan, J., and Arnold, J. Violence by people with men- Scandinavica, 99:120-125, 1999.
tal illness: A consensus statement by advocates and Rupp, A.; Harangoz6, J.; BognSr, G.; Ivan, N.; and Rad6,
researchers. Psychiatric Rehabilitation Journal, I. A szkizofre'nia gazdasigi ko'ltse'gei Magyarorszdgon az
19:67-70, 1996. 1990es 6vekben. Psychiatria Hungarica, 14(2): 131-142,
Moscarelli, M.S.; Capri, S.; and Neri, L. Cost evaluation 1999.
of chronic schizophrenic patients during the first three Salize, HJ., and Rflssler, W. The cost of comprehensive
years after first contact. Schizophrenia Bulletin, care of people with schizophrenia living in the commu-
17(3):421^26, 1991. nity: A cost evaluation from a German catchment area.
Muller, C.F., and Caton, C.L.M. Economic costs of schiz- British Journal of Psychiatry, 169:42-48, 19%.
ophrenia: A post-discharge survey. Medical Care, Sartorius, N.; Fleischhacker, W.; Gjerris, A.; Kern, U.;
21:92-104, 1983. Knapp, M.; Leonard, B.; Lieberman, J.; Jos6 Lopez-
National Health Service Executive. Burdens of Disease. Ibor, J.; van Raay, B.; and Twomey, E. The usefulness
London, U.K.: Department of Health, 19%. of and use of second-generaion antipsychotic medica-
tions: Review of evidence and recommendations by a
Osterheider, M.; Franken-Hiep, K.; and Horn, R.
Task Force of the World Psychiatric Association.
Gesamtkrankenkosten der Schizophrenic und monetare
292
Global Costs of Schizophrenia Schizophrenia Bulletin, Vol. 30, No. 2, 2004
The Authors
Martin Knapp, Ph.D., is Director, Centre for the
Economics of Mental Health, Health Services Research
Department, Institute of Psychiatry, De Crespigny Park,
London, U.K. Roshni Mangalore, M.Sc, is at the
University of Warwick, Conventry, U.K. Judit Simon is at
the University of Oxford, Oxford, U.K.
293
All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately.